IFNG and glioblastoma: For instance, therapeutic vaccination with a combination of synthetic peptide GBM-associated antigen (GAA) epitopes and poly-ICLC (NCT00795457 and NCT00874861) induced a robust IFN-γ production and prolonged the median PFS of patients with GBM to 21 months post-diagnosis.